SDTM-ETL 3.1 User Manual and Tutorial

Size: px
Start display at page:

Download "SDTM-ETL 3.1 User Manual and Tutorial"

Transcription

1 SDTM-ETL 3.1 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: Creating mappings for the AE domain Now that we have created (and executed) mappings for several domains, let us create a mapping for the Adverse Events (AE) domain. If we take a look at our ODM study setup, we notice that there is an Adverse Events form, which is used (optionally) in the second visit. Usually, Adverse Event forms can be used in any visit, so we will do as if there were more visits defined in this study, and allow Adverse Event forms to have been used in any of the visits (StudyEvents). A further look at the Adverse Event form shows that it is only partially suited for mapping with the SDTM. Ideally, the CDASH1 AE form should have been used, as it has an (almost) 1:1 mapping with the SDTM AE domain, but at the time of the current study design, this CDASH form was not available yet. This will happen often in the case of legacy studies. To start, drag-and-drop the AE row in the SDTM table to the bottom of the table, this creating a study-specific instance of the AE domain. Accept the defaults for automatic generation of mappings for STUDYID, DOMAIN, USUBJID and AE.AESEQ: The SDTM Implementation Guide tells us that we should have one record per adverse event per subject. We can translate this into One record per AE.AETERM per USUBJID, this as each ODM record has an IT.AETERM Item with the name Conmed Indication in the form Adverse Events. Please note that also other choices are possible, as long as the choice ensures that there is one record per AE form/subform used. We do however choose for AETERM as it is the SDTM topic variable. Double click the first cell in our newly created row ( MyStudy:AE ). The Domain Editor panel shows up: 1 See the CDISC website at

2 We select two levels of looping, the second being AE.AETERM. If we use define.xml 2.0, there is also a button Set domain keys and sequence. Clicking it pops up the dialog: You can now add some variables using the Add>> button and change the order with the Move up and Move down buttons. In earlier days, the SDTM-IG gave some suggestions for the keys, but most sponsors just copied these without further thinking2. You might e.g. choose for: 2 It is however also not clear whether the FDA is doing anything with this information! The define.xml 2.0 specification states that adding domain keys in the context of a regulatory submission. To our knowledge, the FDA is not loading submission datasets in a database, so we wonder why these keys are necessary...

3 The next time you will edit the domain properties and hold the mouse over the button, you will find: After having edited the domain properties, we can start with the mappings. We do already have a mapping for USUBJID (automatically generated), so we must still generate a mapping for AE.AETERM. It is always good practice to first develop mappings for those SDTM variables that are looping variables (usually that is the topic variable), so let us do this one first. As already stated the ODM has an Item Conmed Indication with OID IT.AETERM. When we click in the SDTM cell for AE.AETERM, we even see that this Item is a hot candidate for the mapping (meaning that it has an annotation that its SDTM target3 is AETERM ): 3 In the ODM, this is either accomplished by the SDSVarName attribute on ItemDef, or by an Alias element having SDTM for the Context attribute.

4 The square around the traffic light indicating that the item is a hot candidate for the SDTM variable AETERM. If the item in the tree is not visible yet, we also can always find the hot candidate using the menu Navigate Find hot SDTM Candidate : Just drag-and-drop the Item Conmed Indication from the left side to the cell AE.AETERM. The following dialog shows up:

5 We accept the default that will retrieve the value from the clinical data ( ItemData Value attribute ) As we want to take care that AE forms from all visits are taken into account (although in this study it is only used in the second visit, as there are only two visits), we need to check the checkbox Generalize for all StudyEvents. Later we will learn how to be more precise which visits exactly must be selected (unimportant in this case) using the Except for... and Only for... buttons. We are also warned that in the ODM, the value for Conmed Indication may be up to 100 characters long, whereas our define.xml template has a default of max. 80 characters for this variable. When we check the checkbox Set SDTM Variable Length to ODM ItemDef Length, this will automatically be corrected, and the SDTM Length will be set to 100 too4. When clicking OK, this correction is again confirmed: The transformation script is now automatically generated: A mapping description is automatically created, which you might want to adapt. The information 4 It is NOT a good idea to set the length for all variables to the SAS-XPT maximum of 200, as this will generate extremely large SAS-XPT data sets that the FDA cannot handle. Also, setting a correct maximum length will help generating an optimized database (see Generating an SDTM database )

6 in it will go into the Description element of the corresponding MethodDef element in the underlying define.xml (in case define.xml 2.0 is used). We can test it using the button Test Transform to XSLT. We get something like: after having used the Test XSLT on ODM Clinical Data button and having provided a file with clinical data for this study. We also see that some subjects have not have any adverse events (e.g. subjects 005, 006, 007). When later executing the mappings, no AE records will be generated for these subjects. Define.xml 2.0 also requires to provide the Origin of each SDTM variable when the context is a regulatory submission. To add it for AETERM, use the menu Edit SDTM Variable Properties and then look for the checkbox New Origin : You can now add the Origin by checking the checkbox followed by clicking the Edit button5. This gives: 5 If you use define.xml 1.0, you will see that Origin is free text, and you will find a text field.

7 In this case, it is clear that the origin is CRF, so we need to check that checkbox: We must associate a define.xml def:leaf with the annotated CRF, but we haven't got one yet, so we need to create one first by returning to the main window, and use the menu Insert Link to annotated CRF 6: 6 If you have annotated your ODM study design well, this should essentially serve the purpose of the annotated CRF. However, the FDA does not accept this yet you still need to provide an oldfashioned PDF, even in the case no paper was used in the study (e.g. in the case of ecrfs)

8 and use the Browse button to add the location of your acrf. You can then add this information again to the AETERM variable using the Edit SDTM Variable again: and also add the page number to the field Page list If you do not have an annotated CRF in PDF format yet, you can of course skip this step, and add the information later. The second SDTM variable we want to develop a mapping for is AE.AEDECOD ( Dictionaryderived term, usually the MedDRA preferred term). As we haven't got anything better, we just use the same mapping as for AE.AETERM for the moment7. The CDISC Notes tell us that the sponsor need to give the dictionary name and version in the Comments column in the define.xml document. This can easily be done by selecting the AE.AEDECOD cell, and then use the menu Edit -> SDTM Variable Properties. We can then add the information in the input field for Comment : 7 If you have a MedDRA database or tool, we can help you generating a connection to it for mapping purposes.

9 The next SDTM variable we can develop a mapping for is the variable AE.AESEV (Severity/Intensity). When we select the cell, we see that there is an ODM hot candidate IT.AESEV ( Severity ), which is however governed by a codelist. As indicated by the square around the traffic light and the blue color of it (indicating there is an associated codelist). To see the details of the codelist at the ODM side, select the Item Severity and then use the menu Navigate -> Select associated CodeList (Ctrl-F2). The selection jumps to the associated CodeList in the ODM tree and expands its tree node: We observe that there are four possibilities with coded values 1, 2, 3 or 4 (these can be seen in the status field at the bottom when selecting a CodeListItem, and decoded values Mild, Moderate, Severe and Life Threatening. The SDTM-IG tells us that there is controlled terminology for AESEV and provides a reference to the NCI website. There we can find that there is a codelist CL.C66769.AESEV which however only has 3 allowed values: MILD, MODERATE and SEVERE. It also states that the codelist is non-extensible. Unfortunately the SDTM-IG is also not very clear on whether one must use that codelist. It states: The severity or intensity of the event. Examples: MILD, MODERATE, SEVERE. Especially, the wording Examples is confusing.

10 We now have the choice between two approaches: a) map the 4 possibible values from the study design to the three values of the recommended SDTM-IG codelist with only 3 values. If we do so, we should document this in the reviewers guide but also in the annotated CRF b) copy our own SEVERITY codelist from the ODM (study design) to the SDTM, and use that. We will use the first approach (only as an example8). Now just drag-and-drop the ItemDef Severity to the SDTM cell AE.AESEV. The following dialog shows up: This time, we do NOT check the button Set SDTM Variable Length to ODM ItemDef Length as we will use a different codelist on the SDTM site. Do not forget to check the box Generalize for all Study Events if it was not automatically checked yet. Clicking OK leads to: 8 In such cases, the mapper should decide himself / herself which of the 2 approaches is most appropriate

11 Where we select Use CodeList from SDTM variable (which is the CDISC-NCI codelist). Then clicking OK leads to: which allows us to do the mapping between both the codelists. As we know that 1 stands for Mild, 2 for Moderate and 3 for Severe, we just use the dropdowns leading to:

12 where we map life threatening to severe. For Missing value, we just map to blank - this will give a null value in the later result. So we have: The button Attempt 1:1 mapping based on coded values can be used in case of long codelists. The system will then try to compare both and come with a suitable proposal for the mappings. After clicking OK, the mapping editor shows up and the result is:

13 So the system has automatically generated a mapping script no need for typing! Of course one can always edit/adapt the mapping script, but in this case, this is not necessary at all. Also note that comment lines (all starting with # have automatically been generated). The next SDTM variable on our list is AE.AESER ( Is this a serious event?). The possible values are Y (Yes) and N (No). We see that there is no corresponding item in the ODM, so we will (arbitrarily) add N values for mild and moderate adverse events, and Y for severe and life threatening adverse events. Drag-and-drop from IT.AESEV (ItemDef: Severity) to the SDTM cell AE.AESER. Check again to generalize for all visits (StudyEvents). We get:

14 We better choose the codelist from the SDTM Variable. Check the radiobutton and then click the button Show Codelist Details : Remark that dependent on which version of CDISC-CT you have chosen when loading the template, you might see slightly different things here. Again, the codelist mapping tool is then displayed. We map to:

15 Which leads to the automatically created mapping script: Also remark the automatically created comment line, allowing us later to remember how the mapping script was generated9. In case such an arbitrary decision is made, it is surely not a bad habit to explain that decision in the Comments field of the define.xml. You can do so using the menu Edit => SDTM Variable Properties, and add your comment in the field Comment : For a regulatory submission, define.xml 2.0 also requires that the Origin is provided, either on the variable level or on the valuelist level. We can easily add it using the New Origin checkbox followed by Edit : 9 And which can also be read by the FDA reviewer when inspecting the Methods in the submitted define.xml file.

16 and in this case set it to Derived. Note: when having finished mapping a domain / dataset, it is surely a good idea to check whether each variable has been assigned an Origin. The absence of it is NOT marked as an error even when using OpenCDISC, as the latter cannot know whether the context of the define.xml is a regulatory submission. The next SDTM variable is AE.AEACN (Action taken with study treatment). When clicking the cell, we see that there is an ODM hot candidate Actions take re study drug. Alternatively, we can search for a hot candidate on the ODM side using the menu Navigate Find hot SDTM Candidate. We find: Drag-and-drop, and generalizing for all StudyEvents gives us the dialog asking us which codelist to use. Again we can use the already associated SDTM codelist:

17 Clicking OK gives us the codelist mapping wizard, which easily leads us to the following mapping: and again, the mapping script is automatically generated:

18 At this point, let us try to execute the full mapping that we have so far on a set of clinical data, just as a check that we are doing the right things. For this, use the menu Transform - Generate Transformation (XSLT) Code for CDISC Dataset-XML (alternatively you can also use Generate Transformation (XSLT) Code for SAS-XPT ) followed by Excecute Transformation (XSLT) Code : Note that there is no checkbox Split records > 200 characters to SUPP-- records as this is not necessary anymore when using Dataset-XML instead of SAS-XPT. We select a file with clinical data. As we want to inspect the results, we check the checkbox View Results in Smart DatasetXML Viewer. Then click Execute Transformation on Clinical Data. The mapping scripts are executed and soon the Smart Dataset-XML Viewer shows up:

19 leading to: There are a few records only, but the results seem to be OK. We can compare directly by selecting the ItemDef: Conmed Indication in the ODM tree, and then use the menu View - Clinical Data which gives us all records for which an adverse event was reported:

20 The next SDTM variable we can tackle is AE.AEREL (Causality). The SDTM-IG states that there currently is no controlled terminology for this variable10. For AEREL there is once again an ODM hot candidate (Relationship to study drug), so this is an easy mapping. Just for the exercise, we will this time use the ODM values, but as these are coded (coded values 03) we want to use the ODM decoded values ( None, Unlikely, Possible, Probable ). So in the dialog, we choose for Use Study CodeList (from ODM) Decoded Values : As our ODM has decoded values for different languages, the system now asks us for which language we want to retrieve the decoded values: 10 The SDTM-IG 1.4 states: Records the investigator's opinion as to the causality of the event to the treatment. ICH E2A and E2B examples include NOT RELATED, UNLIKELY RELATED, POSSIBLY RELATED, RELATED. Controlled Terminology may be defined in the future. Check with regulatory authority for population of this variable. Does this mean that the latter essentially depends on which reviewer you have?

21 We choose english ( en ). Again, the mapping script is automatically created: leading to the following mapping script: Now do the same for the SDTM variable AE.AEACNOTH ( Other action taken ). It can be mapped to ItemDef Actions Taken Other. Once again, use decoded values from the ODM codelist. For the SDTM variable AE.AEOUT, there is again an ODM hot candidate (ItemDef: Outcome). There is an ODM codelist associated, and at the SDTM side, there is already an associated codelist CL.OUT. The usual process leads us to the codelist mapping wizard: and the automatically created mapping script:

22 You can now also easily make similar mappings for the following SDTM variables: AE.AESDTH (Results in Death), AE.AEHOSP (Hospitalization), AE.AESLIFE (Life Threatening), and AE.AECONTRT (Concomitant or additional treatment given). In each case, the associated codelist is CL.NY. Some hints for the ODM items that can be used and the ODM and SDTM codelists involved, are given in the following table: SDTM Variable AESDTH (Results in Death) ODM Item Outcome (IT.AEOUT) ODM Codelist Define.xml codelist CL.AEOUT CL.NY AEHOSP Actions taken, other (Requires or Prolongs (IT.AECONTRT) Hospitalization) CL.AECONTRT CL.NY AESLIFE Severity (IT.AESEV) (Is Life Threatening) CL.AESEV CL.NY AECONTRT (Concomitant or Additional Trtmnt Given) CL.AECONTRT CL.NY Actions taken, other (IT.AECONTRT) For example, for AECONTRT (Concomitant or Additional Trtmnt Given) the mapping to the ODM Actions taken, other, can look like:

23 Note that it depends on the structure and content of your CRF whether absence of additional treatment should be mapped to either N or null for AECONTRT. Executing the already available mappings using the CDISC Dataset-XML format then leads to: Timing variables The SDTM variables AESTDTC (AE start date), AEENDTC (AE end date), AESTDY (Study day of start AE), AEENDY (Study day of end AE), and AEDUR (AE duration) require somewhat more attention. For the first two, the information is available in the ODM ( Derived Start Date11 and Derived Stop Date ). The next two need to be calculated using e.g. the date of the first visit as study day 1. The last (AE duration) should only be submitted (according to the SDTM-IG) in case it was collected as a duration, so it should not be derived. However, just for the exercise, we will calculate it anyway. In SDTM, dates should be given in ISO-8601 format (YYYY-MM-DD). If we look however at the ODM clinical data for e.g. Derived Start Date, we see that these are not in the required ISO-8601 format: The ISO-format is YYYY-MM-DD, e.g. for the first date it should be: However, due to the numerous script functions that we have available, it is pretty easy to make a transformation, after having performed drag-and-drop from the ODM item Derived Start Date to the SDTM cell AESTDTC. For example: 11 It is named derived as it comes from the combination of start year (Item OID IT.AESTYR), start month (IT.AESTMON) and start day (IT.AESTDAY)

24 The first line retrieves the value from the ODM clinical data. The second line takes the first four characters from the retrieved value, the third line the next two characters, and the fourth line the last two characters. If you do not understand how the substring function works, just look for the button near the bottom of the screen, and hold the mouse over it. A tooltip shows up: The fifth line in the script then sets up an if-else structure. In case there is a value for the date, it is reassembled from the individual parts using the dash as separator between year, month and day. The else part is necessary as othewise we would get -- in case there is a missing value for the date. For the Study day of AE start (AE.AESTDY), we need to do some date handling.we will take the visit date of the first visit as study day 1 (see remark 12), and then calculate the value for AE.AESTDY from this and the AE start date. For the former, we can use drag-and-drop from the ODM, this although the datatypes of source and target do not match (red traffic light). We then get the following warning message: In this case, we should have the checkbox Generalize for all StudyEvents unchecked! We can however also easily use the mapping selectors in the mapping editor: 12 In SDTM study days (relative to the reference start date) can either be positive values, or negative values, but NEVER 0. This always needs to be taken into account when calculating study days.

25 So we defined the first visit date as our reference day. Now we define the AE start date, using the already defined variable $AE.AESTDTC. This may look strange at first, but we may always use previously defined (i.e. in a cell before the current one in the same row) scripting variable in read mode. So we write: Also remark that we added some print statements for testing. We know that both dates are in ISO-8601 format, so we can now use the datediff function to calculate the number of days between both dates, and from that, retrieve the study day of AE start: We need to take into account missing values for the AE start date. If we don't, the datediff function will fail and raise an exception (i.e. the execution of the script will crash). Also we need to add 1 to the result, as the first study day is day 1, and not day 0.

26 We need to take into account missing values for the AE start date. If we don't, the datediff function will fail and raise an exception (i.e. the execution of the script will crash). Also we need to add 1 to the result, as the first study day is day 1, and not day 0. We can do similarly for the Study day of AE end (AE.AENDY): Here again, we reuse (but read-only) $AE.AEENDTC, for the calculation of the study day. There is even a simpler way that we will learn about a bit later. We will need reference start date (from DM-RFSTDTC) and reference end date (from DM-RFENDTC) very often (in almost each domain), so we will create some subject global variables that we can then use over and over again in read only mode. For more details, see the tutorial creating and working with global variables. The last SDTM variable we want to provide a mapping for is AE.AEDUR (duration of the AE event). According to the SDTM, it should only be submitted if it was collected as a duration on the CRF. However, for the sake of the exercise, we will derive it here. As we do already have the start and end date, this is very easy, and we can use the datediff() function again. We only need to take missing values into account. The script then looks like:

27 The three last lines take care that the date difference (in days) is put into ISO-8601 duration format. Now, let us once again execute the mapping on a file with clinical data. We again use the menu Transform -> Generate Transformation Code for CDISC Dataset-XML -> Execute Transformation Code. The result as inspected using the Smart Dataset-XML Viewer is: Remark again that AEDUR should normally not be calculated during the mapping, but only be provided when it was collected on the CRF. We did calculate it here just for the sake of the exercise.

SDTM-ETL 3.2 User Manual and Tutorial

SDTM-ETL 3.2 User Manual and Tutorial SDTM-ETL 3.2 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2017-07-29 Adding mappings for the Vital Signs domain After loading and validating the ODM file with metadata, your load

More information

Adding, editing and managing links to external documents in define.xml

Adding, editing and managing links to external documents in define.xml SDTM-ETL 3.1 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2015-05-25 Adding, editing and managing links to external documents in define.xml Define.xml contains the metadata of

More information

SDTM-ETL 3.0 User Manual and Tutorial

SDTM-ETL 3.0 User Manual and Tutorial SDTM-ETL 3.0 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2014-03-29 Creating mappings for the SV (Subject Visits) domain Although Fred Wood, one of the authors of the SDTM Implementation

More information

SDTM-ETL 3.0 User Manual and Tutorial

SDTM-ETL 3.0 User Manual and Tutorial SDTM-ETL 3.0 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2014-02-15 Loading an SDTM template mappings for DM After having loaded and inspected a CDISC ODM file with the study

More information

SDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6

SDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6 SDTM-ETL TM New features in version 1.6 Author: Jozef Aerts XML4Pharma July 2011 p.1/14 Table of Contents Implementation of SEND v.3.0 final...3 Automated creation of the RELREC dataset and records...4

More information

SDTM-ETL. New features in version 3.2. SDTM-ETLTM: New features in v.3.2

SDTM-ETL. New features in version 3.2. SDTM-ETLTM: New features in v.3.2 SDTM-ETL TM New features in version 3.2 Version 3.2 is available since spring 2017 p.1/44 Author: Jozef Aerts XML4Pharma August 2017 Table of Contents Introduction...3 Support for SEND-IG v.3.1...4 Wizards

More information

XML4Pharma's ODM Study Designer New features of version 2010-R1 and 2010-R2

XML4Pharma's ODM Study Designer New features of version 2010-R1 and 2010-R2 XML4Pharma's ODM Study Designer New features of version 2010-R1 and 2010-R2 Author: Jozef Aerts, XML4Pharma Last Version: September 7, 2010 New features of version 2010-R2 Search panel further improved

More information

SDTM-ETL 4.0 Preview of New Features

SDTM-ETL 4.0 Preview of New Features SDTM-ETL 4.0 Preview of New Features Author: Jozef Aerts, XML4Pharma Last update: 2018-12-01 Automated installation of new or additional SDTM/SEND templates When new versions of the SDTM-IG or SEND-IG

More information

SDTM-ETL 3.1 User Manual and Tutorial. Working with the WhereClause in define.xml 2.0. Author: Jozef Aerts, XML4Pharma. Last update:

SDTM-ETL 3.1 User Manual and Tutorial. Working with the WhereClause in define.xml 2.0. Author: Jozef Aerts, XML4Pharma. Last update: SDTM-ETL 3.1 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2014-08-23 Working with the WhereClause in define.xml 2.0 As of define.xml 2.0, it is mandatory to define under which

More information

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Paper CD02 SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Brian Mabe, UCB Biosciences, Raleigh, USA ABSTRACT Many pharmaceutical companies are now entrenched

More information

NCI/CDISC or User Specified CT

NCI/CDISC or User Specified CT NCI/CDISC or User Specified CT Q: When to specify CT? CT should be provided for every variable with a finite set of valid values (e.g., the variable AESEV in ADAE can have the values MILD, MODERATE or

More information

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania PharmaSUG 2013 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis

More information

Dealing with changing versions of SDTM and Controlled Terminology (CT)

Dealing with changing versions of SDTM and Controlled Terminology (CT) CDISC UK Network Breakout session Notes 07/06/16 Afternoon Session 1: Dealing with changing versions of SDTM and Controlled Terminology (CT) How do people manage this? Is this managed via a sponsor Standards

More information

Study Data Reviewer s Guide Completion Guideline

Study Data Reviewer s Guide Completion Guideline Study Data Reviewer s Guide Completion Guideline 22-Feb-2013 Revision History Date Version Summary 02-Nov-2012 0.1 Draft 20-Nov-2012 0.2 Added Finalization Instructions 10-Jan-2013 0.3 Updated based on

More information

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India Paper CD15 PhUSE 2016 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences,

More information

Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata

Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata Paper SD02 Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata Dr. Philippe Verplancke, XClinical GmbH, Munich, Germany ABSTRACT define.xml is often created at the end of

More information

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania PharmaSUG 2014 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data

More information

Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA

Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA PharmaSUG 2016 - Paper SS12 Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA ABSTRACT SAS Clinical Data Integration simplifies the

More information

Now let s take a look

Now let s take a look 1 2 3 4 Manage assets across the end to end life cycle of your studies This includes forms, datasets, terminologies, files, links and more, for example: - Studies may contain the protocol, a set of Forms,

More information

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 PharmaSUG 2018 - Paper SS-15 It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 ABSTRACT Supriya Davuluri, PPD, LLC, Morrisville, NC There are some obvious challenges

More information

Aquila's Lunch And Learn CDISC The FDA Data Standard. Disclosure Note 1/17/2014. Host: Josh Boutwell, MBA, RAC CEO Aquila Solutions, LLC

Aquila's Lunch And Learn CDISC The FDA Data Standard. Disclosure Note 1/17/2014. Host: Josh Boutwell, MBA, RAC CEO Aquila Solutions, LLC Aquila's Lunch And Learn CDISC The FDA Data Standard Host: Josh Boutwell, MBA, RAC CEO Aquila Solutions, LLC Disclosure Note This free training session will be placed on Aquila s website after the session

More information

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity John Brega Linda Collins PharmaStat LLC Topics Part 1: A Standard with Many Uses Status of the Define.xml Standard

More information

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting CDASH Standards and EDC CRF Library Guang-liang Wang September 18, 2014 2014 Q3 DCDISC Meeting 1 Disclaimer The content of this presentation does not represent the views of my employer or any of its affiliates.

More information

Implementing CDISC Using SAS. Full book available for purchase here.

Implementing CDISC Using SAS. Full book available for purchase here. Implementing CDISC Using SAS. Full book available for purchase here. Contents About the Book... ix About the Authors... xv Chapter 1: Implementation Strategies... 1 The Case for Standards... 1 Which Models

More information

Dataset-XML - A New CDISC Standard

Dataset-XML - A New CDISC Standard Dataset-XML - A New CDISC Standard Lex Jansen Principal Software Developer @ SAS CDISC XML Technologies Team Single Day Event CDISC Tools and Optimization September 29, 2014, Cary, NC Agenda Dataset-XML

More information

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA PharmaSUG 2017 - Paper DS23 The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA ABSTRACT Since FDA released the Analysis

More information

What is high quality study metadata?

What is high quality study metadata? What is high quality study metadata? Sergiy Sirichenko PhUSE Annual Conference Barcelona, 2016 What is study metadata? Trial Design domains Reviewer s Guides acrf Define.xml Conclusion Topics What is study

More information

Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide

Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide Paper DS06 Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide Kristin Kelly, Pinnacle 21 LLC, Plymouth Meeting, PA, USA Michael Beers, Pinnacle 21 LLC, Plymouth Meeting,

More information

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development PharmaSUG 2018 - Paper DS-15 Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development Aakar Shah, Pfizer Inc; Tracy Sherman, Ephicacy Consulting Group, Inc.

More information

Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis

Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis Prepared by the CDISC Analysis Data Model Team Notes to Readers This Analysis model uses the principles, structure and standards described

More information

How to handle different versions of SDTM & DEFINE generation in a Single Study?

How to handle different versions of SDTM & DEFINE generation in a Single Study? Paper CD15 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai,

More information

Experience of electronic data submission via Gateway to PMDA

Experience of electronic data submission via Gateway to PMDA PharmaSUG 2018 - Paper EP-21 ABSTRACT Experience of electronic data submission via Gateway to PMDA Iori Sakakibara, Kumiko Kimura, Amgen Astellas BioPharma K.K. and Laurence Carpenter, Amgen Ltd PMDA started

More information

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments... From Implementing CDISC Using SAS. Full book available for purchase here. Contents About This Book... xi About The Authors... xvii Acknowledgments... xix Chapter 1: Implementation Strategies... 1 Why CDISC

More information

Lex Jansen Octagon Research Solutions, Inc.

Lex Jansen Octagon Research Solutions, Inc. Converting the define.xml to a Relational Database to enable Printing and Validation Lex Jansen Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D PhUSE 2009, Basel,

More information

Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS

Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS Agenda Introduction to the SAS Clinical Standards Toolkit (CST) Define-XML History and Background What is Define-XML?

More information

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 The Wonderful World of Define.xml.. Practical Uses Today Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 Agenda Introduction to Formedix What is Define.xml? Features and Benefits

More information

Generating Define.xml from Pinnacle 21 Community

Generating Define.xml from Pinnacle 21 Community PharmaSUG 2018 - Paper AD-29 ABSTRACT Generating Define.xml from Pinnacle 21 Community Pinky Anandani Dutta, Inclin, Inc Define.xml is an XML document that describes the structure and contents (metadata

More information

OpenCDISC Validator 1.4 What s New?

OpenCDISC Validator 1.4 What s New? OpenCDISC Validator 1.4 What s New? Bay Area CDISC Implementation Network 23 May 2013 David Borbas Sr Director, Data Management Jazz Pharmaceuticals, Inc. Disclaimers The opinions expressed in this presentation

More information

Customer oriented CDISC implementation

Customer oriented CDISC implementation Paper CD10 Customer oriented CDISC implementation Edelbert Arnold, Accovion GmbH, Eschborn, Germany Ulrike Plank, Accovion GmbH, Eschborn, Germany ABSTRACT The Clinical Data Interchange Standards Consortium

More information

Facilitating Data Integration for Regulatory Submissions

Facilitating Data Integration for Regulatory Submissions SCSUG2010 Facilitating Data Integration for Regulatory Submissions John R. Gerlach, SAS / CDISC Analyst, Hamilton, NJ John C. Bowen (Retired), Merck & Co., Rahway, NJ ABSTRACT The process of integrating

More information

Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences

Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences 1 Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences 2 Content Standards Technical Standards SDTM v1.1 SDTM IG v3.1.1

More information

SAS offers technology to facilitate working with CDISC standards : the metadata perspective.

SAS offers technology to facilitate working with CDISC standards : the metadata perspective. SAS offers technology to facilitate working with CDISC standards : the metadata perspective. Mark Lambrecht, PhD Principal Consultant, Life Sciences SAS Agenda SAS actively supports CDISC standards Tools

More information

PhUSE Paper SD09. "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland

PhUSE Paper SD09. Overnight Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland Paper SD09 "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland ABSTRACT This demonstration shows how legacy data (in any format)

More information

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit Lex Jansen Principal Software Developer @ SAS PharmaSUG 2016 Agenda Why Analysis Results Metadata?

More information

IS03: An Introduction to SDTM Part II. Jennie Mc Guirk

IS03: An Introduction to SDTM Part II. Jennie Mc Guirk IS03: An Introduction to SDTM Part II Jennie Mc Guirk SDTM Framework 1. Where should the data go? 3. What is the minimum information needed? 2. What type of information should it contain? SDTM Framework:

More information

Define.xml 2.0: More Functional, More Challenging

Define.xml 2.0: More Functional, More Challenging Define.xml 2.0: More Functional, More Challenging Bay Area CDISC Implementation Network 24 July 2013 John Brega, PharmaStat LLC Presentation Objectives 1. Introduce the new features in Define.xml 2.0 with

More information

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams CDASH MODEL 1.0 AND CDASHIG 2.0 Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams 1 What is CDASH? Clinical Data Acquisition Standards Harmonization (CDASH) Standards for the collection

More information

Updates on CDISC Standards Validation

Updates on CDISC Standards Validation Updates on CDISC Standards Validation NJ CDISC User Group September 19, 2013 Topics CDISC standards validation initiative FDA update on SEND checks OpenCDISC v1.4.1 release OpenCDISC plans 2 CDISC validation

More information

Define 2.0: What is new? How to switch from 1.0 to 2.0? Presented by FH-Prof.Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria

Define 2.0: What is new? How to switch from 1.0 to 2.0? Presented by FH-Prof.Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria 1 Define 2.0: What is new? How to switch from 1.0 to 2.0? Presented by FH-Prof.Dr. Jozef Aerts University of Applied Sciences FH Joanneum Graz, Austria 2 What's new in define.xml 2.0? Based on ODM 1.3(.2)

More information

Introduction to Define.xml

Introduction to Define.xml Introduction to Define.xml Bay Area CDISC Implementation Network 4 April 2008 John Brega, PharmaStat LLC Presentation Objectives 1. Introduce the concept and purpose of define.xml 2. Introduce the published

More information

SDTM Validation Rules in XQuery

SDTM Validation Rules in XQuery SDTM Validation Rules in XQuery FH-Prof. Dr. Jozef Aerts Univ. Appl. Sciences FH Joanneum Graz, Austria Can you understand the following validation rule (part 1)? SDTM Validation Rules in XQuery Jozef

More information

Advantages of a real end-to-end approach with CDISC standards

Advantages of a real end-to-end approach with CDISC standards Advantages of a real end-to-end approach with CDISC standards Dr. Philippe Verplancke CEO XClinical GmbH 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views and opinions expressed

More information

Define.xml - Tips and Techniques for Creating CRT - DDS

Define.xml - Tips and Techniques for Creating CRT - DDS Paper CD09 Define.xml - Tips and Techniques for Creating CRT - DDS Julie Maddox, SAS Institute Inc., Cary, NC, USA Mark Lambrecht, SAS Institute Inc., Tervuren, Belgium ABSTRACT The Case Report Tabulation

More information

Data Integrity through DEFINE.PDF and DEFINE.XML

Data Integrity through DEFINE.PDF and DEFINE.XML Data Integrity through DEFINE.PDF and DEFINE.XML Sy Truong, Meta Xceed, Inc, Fremont, CA ABSTRACT One of the key questions asked in determining if an analysis dataset is valid is simply, what did you do

More information

Common Programming Errors in CDISC Data

Common Programming Errors in CDISC Data ABSTRACT PharmaSUG 2017 - Paper DS15 Common Programming Errors in CDISC Data Sergiy Sirichenko, Pinnacle 21 Data in standardized format is now a required part of regulatory submissions. CDISC standards

More information

Standards Metadata Management (System)

Standards Metadata Management (System) Standards Metadata Management (System) Kevin Lee, MarkLogic COPYRIGHT 2015 MARKLOGIC CORPORATION. ALL RIGHTS RESERVED. Agenda Regulatory Requirement on Clinical Trial Standards(i.e., CDISC and ectd) Standards

More information

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat PharmaSUG Single Day Event San Francisco Bay Area 2015-02-10 What is the Computational Sciences Symposium? CSS originally formed to help FDA

More information

CDISC SDTM and ADaM Real World Issues

CDISC SDTM and ADaM Real World Issues CDISC SDTM and ADaM Real World Issues Washington DC CDISC Data Standards User Group Meeting Sy Truong President MXI, Meta-Xceed, Inc. http://www.meta-x.com Agenda CDISC SDTM and ADaM Fundamentals CDISC

More information

How to write ADaM specifications like a ninja.

How to write ADaM specifications like a ninja. Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation

More information

DIA 11234: CDER Data Standards Common Issues Document webinar questions

DIA 11234: CDER Data Standards Common Issues Document webinar questions Q: What is the preferred data definition format for ADaM analysis data, define.xml or define.pdf? 1 ADaM Define File Q: The CRTDDS does not describe how to submit a define.xml for ADaM. Does CDER expect

More information

CS05 Creating define.xml from a SAS program

CS05 Creating define.xml from a SAS program CS05 Creating define.xml from a SAS program Jørgen Mangor Iversen LEO Pharma A/S 21 November 2013 LEO Pharma About LEO Pharma A/S Independent, research-based pharmaceutical company Founded in 1908 Employs

More information

OC RDC 4.6. User Guide

OC RDC 4.6. User Guide OC RDC 4.6 Read-Only User Guide Version 1.0 Page 1 of 25 TABLE OF CONTENTS ACCESSING OC RDC...3 Steps for Obtaining Access...3 Logging On...4 Password Changes...5 Computer System and Security...5 VIEWING

More information

Define.xml tools supporting SEND/SDTM data process

Define.xml tools supporting SEND/SDTM data process Define.xml tools supporting SEND/SDTM data process - Using SAS Clinical Standards Toolkit PRESENTER / Kirsten Walther Langendorf DATE / 11. Oct 2017 OUTLINE Business Process High-level SEND process Creating

More information

Best Practices for E2E DB build process and Efficiency on CDASH to SDTM data Tao Yang, FMD K&L, Nanjing, China

Best Practices for E2E DB build process and Efficiency on CDASH to SDTM data Tao Yang, FMD K&L, Nanjing, China PharmaSUG China 2018 - Paper 73 Best Practices for E2E DB build process and Efficiency on CDASH to SDTM data Tao Yang, FMD K&L, Nanjing, China Introduction of each phase of the trial It is known to all

More information

OC RDC HTML User Guide

OC RDC HTML User Guide CRA - Monitor OC RDC 4.5.3 HTML User Guide Page 1 of 46 TABLE OF CONTENTS Accessing OC RDC Steps for Access Logging On Change Password Computer and System Security Study and Site 3 4 5 5 6 Navigating OC

More information

Linking Metadata from CDASH to ADaM Author: João Gonçalves Business & Decision Life Sciences, Brussels, Belgium

Linking Metadata from CDASH to ADaM Author: João Gonçalves Business & Decision Life Sciences, Brussels, Belgium PhUSE 2016 Paper CD10 Linking Metadata from CDASH to ADaM Author: João Gonçalves Business & Decision Life Sciences, Brussels, Belgium ABSTRACT CDISC standards include instructions describing how variables

More information

Mapping Corporate Data Standards to the CDISC Model. David Parker, AstraZeneca UK Ltd, Manchester, UK

Mapping Corporate Data Standards to the CDISC Model. David Parker, AstraZeneca UK Ltd, Manchester, UK Mapping Corporate Data Standards to the CDISC Model David Parker, AstraZeneca UK Ltd, Manchester, UK Introduction Discuss CDISC Case Report Tabulations Data Definition, Study Data Tabulation Model, Operational

More information

CDISC Standards and the Semantic Web

CDISC Standards and the Semantic Web CDISC Standards and the Semantic Web Dave Iberson-Hurst 12 th October 2015 PhUSE Annual Conference, Vienna 1 Abstract With the arrival of the FDA guidance on electronic submissions, CDISC SHARE and the

More information

Optimization of the traceability when applying an ADaM Parallel Conversion Method

Optimization of the traceability when applying an ADaM Parallel Conversion Method SI04 Optimization of the traceability when applying an ADaM Parallel Conversion Method Roxane Debrus ADaM Conversion Process Agenda %LIB_QC_contents_html %adam_sdtm_compa Conclusion ADaM Conversion Process

More information

Introduction to ADaM and What s new in ADaM

Introduction to ADaM and What s new in ADaM Introduction to ADaM and What s new in ADaM Italian CDISC UN Day - Milan 27 th October 2017 Silvia Faini Principal Statistical Programmer CROS NT - Verona ADaM Purpose Why are standards needed in analysis

More information

InForm Training Exercises For Data Managers

InForm Training Exercises For Data Managers InForm 4.6 for CTC Studies TM InForm Training Exercises For Data Managers Version 1.0 15 May 2013 Copyright NHMRC Clinical Trials Centre Page 1 of 42 List of Exercises InForm Training Exercises for Data

More information

ORACLE RDC ONSITE RESEARCH COORDINATOR TRAINING

ORACLE RDC ONSITE RESEARCH COORDINATOR TRAINING ORACLE RDC ONSITE RESEARCH COORDINATOR TRAINING TRAINING REQUIREMENTS RDC system training is designed and conducted for access to OnSite. Additional RDC training will be provided on a per study basis by

More information

PMDA Valida+on Rules. Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency. Max Kanevsky December 10, 2015

PMDA Valida+on Rules. Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency. Max Kanevsky December 10, 2015 PMDA Valida+on Rules Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency Max Kanevsky December 10, 2015 Presenter Max Kanevsky Founder of OpenCDISC CEO of Pinnacle

More information

CDISC Standards End-to-End: Enabling QbD in Data Management Sam Hume

CDISC Standards End-to-End: Enabling QbD in Data Management Sam Hume CDISC Standards End-to-End: Enabling QbD in Data Management Sam Hume 1 Shared Health and Research Electronic Library (SHARE) A global electronic repository for developing, integrating

More information

Legacy to SDTM Conversion Workshop: Tools and Techniques

Legacy to SDTM Conversion Workshop: Tools and Techniques Legacy to SDTM Conversion Workshop: Tools and Techniques Mike Todd President Nth Analytics Legacy Data Old studies never die Legacy studies are often required for submissions or pharmacovigilence. Often

More information

PhUSE EU Connect Paper PP15. Stop Copying CDISC Standards. Craig Parry, SyneQuaNon, Diss, England

PhUSE EU Connect Paper PP15. Stop Copying CDISC Standards. Craig Parry, SyneQuaNon, Diss, England Paper PP15 Abstract Stop Copying CDISC Standards Craig Parry, SyneQuaNon, Diss, England We repeatedly see repositories which require a large amount of front loading, a lot of duplicating of the Clinical

More information

SciGraphica. Tutorial Manual - Tutorials 1and 2 Version 0.8.0

SciGraphica. Tutorial Manual - Tutorials 1and 2 Version 0.8.0 SciGraphica Tutorial Manual - Tutorials 1and 2 Version 0.8.0 Copyright (c) 2001 the SciGraphica documentation group Permission is granted to copy, distribute and/or modify this document under the terms

More information

Investigator Site OC RDC PDF User Guide

Investigator Site OC RDC PDF User Guide Investigator Site OC RDC PDF User Guide Version 1.0 Page 1 of 40 TABLE OF CONTENTS Accessing OC RDC Steps for Access 3 Logging On 4 Change Password 4 Laptop and System Security 5 Change Study 5 Navigating

More information

ODM The Operational Efficiency Model: Using ODM to Deliver Proven Cost and Time Savings in Study Set-up

ODM The Operational Efficiency Model: Using ODM to Deliver Proven Cost and Time Savings in Study Set-up ODM The Operational Efficiency Model: Using ODM to Deliver Proven Cost and Time Savings in Study Set-up Mark Wheeldon, CEO, Formedix Bay Area User Group Meeting, 15 th July 2010 Who are we? Proven Business

More information

Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop

Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop Taming the SHREW SDTM Heuristic Research and Evaluation Workshop September 13, 2013 Carlo Radovsky 2 Overview Introductions The Backstory CDISC IntraChange History of a Rule The Challenge Discuss Amongst

More information

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA PharmaSUG 2015 - Paper IB09 Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA ABSTRACT A submission to FDA for an NDA (New Drug Application) or

More information

Material covered in the Dec 2014 FDA Binding Guidances

Material covered in the Dec 2014 FDA Binding Guidances Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes Sandra Minjoe Senior ADaM Consultant Preparing ADaM and Related Files for Submission Presentation Focus Material

More information

Lex Jansen Octagon Research Solutions, Inc.

Lex Jansen Octagon Research Solutions, Inc. Converting the define.xml to a Relational Database to Enable Printing and Validation Lex Jansen Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D * PharmaSUG 2009,

More information

R1 Test Case that tests this Requirement Comments Manage Users User Role Management

R1 Test Case that tests this Requirement Comments Manage Users User Role Management 2/19/2014 CDISC SHARE Requirements Page 1 of 23 Number Name Req ID Requirement Manage Users 2.1.1 User Role Manage Users 2.1.1 User Role Manage Users 2.1.1 User Role Manage Users 2.1.1 User Role Manage

More information

SciGraphica. Tutorial Manual - Tutorial 3 Version 0.8.0

SciGraphica. Tutorial Manual - Tutorial 3 Version 0.8.0 SciGraphica Tutorial Manual - Tutorial 3 Version 0.8.0 Copyright (c) 2001 The SciGraphica documentation group Permission is granted to copy, distribute and/or modify this document under the terms of the

More information

Helping The Define.xml User

Helping The Define.xml User Paper TT01 Helping The Define.xml User Dave Iberson-Hurst, Assero Limited, Teignmouth, United Kingdom ABSTRACT The FDA often comment at industry gatherings on the quality of define.xml files received as

More information

eiconsole for Healthcare Getting Started Tutorial

eiconsole for Healthcare Getting Started Tutorial eiconsole for Healthcare Getting Started Tutorial https://cms.pilotfishtechnology.com/eiconsole-for-healthcare-getting-started-tutorial Welcome to the eiconsole for Healthcare Getting Started Tutorial.

More information

eiconsole for Healthcare Getting Started Tutorial

eiconsole for Healthcare Getting Started Tutorial eiconsole for Healthcare Getting Started Tutorial http://cms.pilotfishtechnology.com/eiconsole-for-healthcare-getting-started-tutorial Welcome to the eiconsole for Healthcare Getting Started Tutorial.

More information

Challenges with the interpreta/on of CDISC - Who can we trust?

Challenges with the interpreta/on of CDISC - Who can we trust? Challenges with the interpreta/on of CDISC - Who can we trust? Linda Palm Simonsson linda.simonsson@i- mind.se CD01 #PhUSE14 - London 2014-10- 13 Abstract Many smaller companies have none or very linle

More information

Codelists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California

Codelists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California ABSTRACT PharmaSUG 2016 - Paper DS16 lists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California Programming SDTM and ADaM data sets for a single

More information

Standards Driven Innovation

Standards Driven Innovation Standards Driven Innovation PhUSE Annual Conference 2014 Frederik Malfait IMOS Consulting GmbH, Hoffmann-La Roche AG Managing Standards 2 Data Standards Value Proposition Standards are increasingly mandated

More information

ORACLE RDC ONSITE RESEARCH COORDINATOR TRAINING

ORACLE RDC ONSITE RESEARCH COORDINATOR TRAINING ORACLE RDC ONSITE RESEARCH COORDINATOR TRAINING TRAINING REQUIREMENTS RDC system training is designed and conducted for access to OnSite. Additional RDC training will be provided on a per study basis by

More information

CDISC Journal. Generating a cabig Patient Study Calendar from a Study Design in ODM with Study Design Model Extension. By Jozef Aerts.

CDISC Journal. Generating a cabig Patient Study Calendar from a Study Design in ODM with Study Design Model Extension. By Jozef Aerts. CDISC Journal Clinical Data Interchange Standards Consortium october 2011 Generating a cabig Patient Study Calendar from a Study Design in ODM with Study Design Model Extension By Jozef Aerts Abstract

More information

MaintScape Training Course Table of Contents

MaintScape Training Course Table of Contents MaintScape Training Course Table of Contents Table of Contents... 1 Training Course Requirements... 3 Overview and Main Modules... 3 Search Window... 4 Reports are produced from the Search Window... 6

More information

Considerations on creation of SDTM datasets for extended studies

Considerations on creation of SDTM datasets for extended studies 13/May/2016 As one of the activities of CDISC Japan User Group (CJUG), a small group, "Extension study team" was organized in 2015. The team discussed what kind of approach works better for SDTM creation

More information

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets PharmaSUG 2017 - Paper SS09 Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets Xiangchen (Bob) Cui, Min Chen, and Letan (Cleo) Lin, Alkermes Inc.,

More information

Creating Define-XML v2 with the SAS Clinical Standards Toolkit

Creating Define-XML v2 with the SAS Clinical Standards Toolkit SAS Super Demo Creating Define-XML v2 with the SAS Clinical Standards Toolkit Lex Jansen, SAS SAS Clinical Standards Toolkit 1.7 INTRODUCTION Framework to primarily support Clinical Research activities

More information

Standardizing FDA Data to Improve Success in Pediatric Drug Development

Standardizing FDA Data to Improve Success in Pediatric Drug Development Paper RA01 Standardizing FDA Data to Improve Success in Pediatric Drug Development Case Study: Harmonizing Hypertensive Pediatric Data across Sponsors using SAS and the CDISC Model Julie Maddox, SAS Institute,

More information

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on DCDISC Users Group Nate Freimark Omnicare Clinical Research Presented on 2011-05-12 1 Disclaimer The opinions provided are solely those of the author and not those of the ADaM team or Omnicare Clinical

More information

Taming Rave: How to control data collection standards?

Taming Rave: How to control data collection standards? Paper DH08 Taming Rave: How to control data collection standards? Dimitri Kutsenko, Entimo AG, Berlin, Germany Table of Contents Introduction... 1 How to organize metadata... 2 How to structure metadata...

More information